University labs play a vital role in advancing drug discovery and pharmaceutical innovation. Although these discoveries provide new solutions to medical challenges, improve patient outcomes, and promote economic growth, advancing them from the lab into clinical practice remains a major challenge. This highlights the need for sustained funding and support to deliver new therapies to patients. Helping to address this challenge, the Blavatnik Biomedical Accelerator (BBA) at Harvard supports the progression of translational biomedical research toward commercial and clinical applications. Established through a gift from the Blavatnik Family Foundation in 2013, the BBA has announced its latest cohort of awardees for 2025, supporting 10 biomedical technologies focused on tackling urgent medical challenges, including food allergies, genetic disorders, autoimmune diseases, metabolic disorders, and cancer.
Speeding Discoveries from Lab to Patients
Learn More
Discover the cutting-edge science we fund
Providing many of the world's best researchers, scientists, and universities with support, and funding to discover breakthroughs that solve humankind's greatest challenges.
See how we support great cultural institutions around the world
The Foundation contributes to renowned institutions that showcase the breadth of arts and culture, including performance, exhibition and education.
Visit the Blavatnik Archive
The Blavatnik Archive is a nonprofit foundation dedicated to preserving and disseminating materials that contribute to the study of 20th-century Jewish and world history, with a special emphasis on World War I, World War II, and Soviet Russia.